In Segment A, individuals will obtain distinctive doses and schedules of oral ABBV-744 tablet to discover Protected dosing program. Additional individuals are going to be enrolled on the determined monotherapy dosign routine. In Section B, members will acquire oral ruxolitinib and ABBV-744 might be given as "incorporate-on" therapy. In Section https://chiefx000hsc1.blogpixi.com/profile